These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25329662)

  • 61. Nonparametric models and methods for designs with dependent censored data: part I.
    O'Gorman JT; Akritas MG
    Biometrics; 2001 Mar; 57(1):88-95. PubMed ID: 11252623
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A note on one-sided tests with multiple endpoints.
    Perlman MD; Wu L
    Biometrics; 2004 Mar; 60(1):276-9; discussion 279-80. PubMed ID: 15032799
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adjusting O'Brien's test to control type I error for the generalized nonparametric Behrens-Fisher problem.
    Huang P; Tilley BC; Woolson RF; Lipsitz S
    Biometrics; 2005 Jun; 61(2):532-9. PubMed ID: 16011701
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of radial versus focused extracorporeal shock waves in plantar fasciitis using functional measures.
    Lohrer H; Nauck T; Dorn-Lange NV; Schöll J; Vester JC
    Foot Ankle Int; 2010 Jan; 31(1):1-9. PubMed ID: 20067715
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sample size determination using an interim analysis.
    Bristol DR
    J Biopharm Stat; 1993 Sep; 3(2):159-66. PubMed ID: 8220401
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bayesian sample size determination for a clinical trial with correlated continuous and binary outcomes.
    Stamey JD; Natanegara F; Seaman JW
    J Biopharm Stat; 2013; 23(4):790-803. PubMed ID: 23786161
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Group sequential distribution-free methods for the analysis of multivariate observations.
    Su JQ; Lachin JM
    Biometrics; 1992 Dec; 48(4):1033-42. PubMed ID: 1290797
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Directional multivariate tests rejecting null and negative effects in all variables.
    Glimm E; Läuter J
    Biom J; 2010 Dec; 52(6):757-70. PubMed ID: 20669248
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A double blind, randomised, parallel group study on the efficacy and safety of treating acute lateral ankle sprain with oral hydrolytic enzymes.
    Kerkhoffs GM; Struijs PA; de Wit C; Rahlfs VW; Zwipp H; van Dijk CN
    Br J Sports Med; 2004 Aug; 38(4):431-5. PubMed ID: 15273178
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Alternative methods for testing treatment effects on the basis of multiple outcomes: simulation and case study.
    Yoon FB; Fitzmaurice GM; Lipsitz SR; Horton NJ; Laird NM; Normand SL
    Stat Med; 2011 Jul; 30(16):1917-32. PubMed ID: 21538986
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Equivalence assessment for interchangeability based on two-sided tests.
    Dong X; Tsong Y
    J Biopharm Stat; 2014; 24(6):1312-31. PubMed ID: 25032976
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multivariate nonparametric techniques for astigmatism analysis.
    Tongbai RR; Yu F; Miller KM
    J Cataract Refract Surg; 2010 Apr; 36(4):594-602. PubMed ID: 20362851
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Testing for qualitative heterogeneity: An application to composite endpoints in survival analysis.
    Oulhaj A; El Ghouch A; Holman RR
    Stat Methods Med Res; 2019 Jan; 28(1):151-169. PubMed ID: 28670972
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sequential boundaries approach in clinical trials with unequal allocation ratios.
    Jafari P; Ayatollahi SM; Behboodian J
    BMC Med Res Methodol; 2006 Jan; 6():1. PubMed ID: 16412232
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Optimal two-stage designs for clinical trials based on safety and efficacy.
    Thall PF; Cheng SC
    Stat Med; 2001 Apr; 20(7):1023-32. PubMed ID: 11276033
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Radiotherapy dose distribution prediction for breast cancer using deformable image registration.
    Bai X; Wang B; Wang S; Wu Z; Gou C; Hou Q
    Biomed Eng Online; 2020 May; 19(1):39. PubMed ID: 32471419
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Variable criteria sequential stopping rule: Validity and power with repeated measures ANOVA, multiple correlation, MANOVA and relation to Chi-square distribution.
    Fitts DA
    Behav Res Methods; 2018 Oct; 50(5):1988-2003. PubMed ID: 28936614
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multivariate time-to-event analysis of multiple adverse events of drugs in integrated analyses.
    Güttner A; Kübler J; Pigeot I
    Stat Med; 2007 Mar; 26(7):1518-31. PubMed ID: 16903003
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Power analyses for negative binomial models with application to multiple sclerosis clinical trials.
    Rettiganti M; Nagaraja HN
    J Biopharm Stat; 2012; 22(2):237-59. PubMed ID: 22251172
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A self-designing rule for clinical trials with arbitrary response variables.
    Hartung J
    Control Clin Trials; 2001 Apr; 22(2):111-6. PubMed ID: 11306149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.